116 related articles for article (PubMed ID: 34327974)
1. microRNA-486-5p functions as a tumor suppressor in gastric carcinoma via directly targeting KDM5B.
Li YB; Fan XY; Ning L; Li SK; Yu ZP
J Biol Regul Homeost Agents; 2021 Jul; 35(Special Issue on Internal Medicine n.1):. PubMed ID: 34327974
[No Abstract] [Full Text] [Related]
2. miR424-5p functions as an anti-oncogene in cervical cancer cell growth by targeting KDM5B via the Notch signaling pathway.
Zhou Y; An Q; Guo RX; Qiao YH; Li LX; Zhang XY; Zhao XL
Life Sci; 2017 Feb; 171():9-15. PubMed ID: 28082020
[TBL] [Abstract][Full Text] [Related]
3. Original Research: miR-194 inhibits proliferation and invasion and promotes apoptosis by targeting KDM5B in esophageal squamous cell carcinoma cells.
Cui G; Liu D; Li W; Li Y; Liang Y; Shi W; Zhao S
Exp Biol Med (Maywood); 2017 Jan; 242(1):45-52. PubMed ID: 27480251
[TBL] [Abstract][Full Text] [Related]
4. miR-194 inhibits gastric cancer cell proliferation and tumorigenesis by targeting KDM5B.
Bao J; Zou JH; Li CY; Zheng GQ
Eur Rev Med Pharmacol Sci; 2016 Nov; 20(21):4487-4493. PubMed ID: 27874950
[TBL] [Abstract][Full Text] [Related]
5. Investigation of the potential theranostic role of KDM5B/miR-29c signaling axis in paclitaxel resistant endometrial carcinoma.
Li L; Shou H; Wang Q; Liu S
Gene; 2019 Apr; 694():76-82. PubMed ID: 30658067
[TBL] [Abstract][Full Text] [Related]
6. Aberrant KDM5B expression promotes aggressive breast cancer through MALAT1 overexpression and downregulation of hsa-miR-448.
Bamodu OA; Huang WC; Lee WH; Wu A; Wang LS; Hsiao M; Yeh CT; Chao TY
BMC Cancer; 2016 Feb; 16():160. PubMed ID: 26917489
[TBL] [Abstract][Full Text] [Related]
7. Identification of the upstream regulators of KDM5B in gastric cancer.
Zhao LF; Qi FY; Zhang JG; Pang JR; Ren HM; Shen DD; Zhao LJ; Qi L; Liu HM; Zheng YC
Life Sci; 2022 Jun; 298():120458. PubMed ID: 35248525
[TBL] [Abstract][Full Text] [Related]
8. SNHG1 promotes malignant biological behaviors of glioma cells via microRNA-154-5p/miR-376b-3p- FOXP2- KDM5B participating positive feedback loop.
Li H; Xue Y; Ma J; Shao L; Wang D; Zheng J; Liu X; Yang C; He Q; Ruan X; Li Z; Liu Y
J Exp Clin Cancer Res; 2019 Feb; 38(1):59. PubMed ID: 30728054
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of the JmjC histone demethylase KDM5B in human carcinogenesis: involvement in the proliferation of cancer cells through the E2F/RB pathway.
Hayami S; Yoshimatsu M; Veerakumarasivam A; Unoki M; Iwai Y; Tsunoda T; Field HI; Kelly JD; Neal DE; Yamaue H; Ponder BA; Nakamura Y; Hamamoto R
Mol Cancer; 2010 Mar; 9():59. PubMed ID: 20226085
[TBL] [Abstract][Full Text] [Related]
10. KDM5B histone demethylase controls epithelial-mesenchymal transition of cancer cells by regulating the expression of the microRNA-200 family.
Enkhbaatar Z; Terashima M; Oktyabri D; Tange S; Ishimura A; Yano S; Suzuki T
Cell Cycle; 2013 Jul; 12(13):2100-12. PubMed ID: 23759590
[TBL] [Abstract][Full Text] [Related]
11. Overexpressed KDM5B is associated with the progression of glioma and promotes glioma cell growth via downregulating p21.
Dai B; Hu Z; Huang H; Zhu G; Xiao Z; Wan W; Zhang P; Jia W; Zhang L
Biochem Biophys Res Commun; 2014 Nov; 454(1):221-7. PubMed ID: 25450384
[TBL] [Abstract][Full Text] [Related]
12. MicroRNAs regulate KDM5 histone demethylases in breast cancer cells.
Denis H; Van Grembergen O; Delatte B; Dedeurwaerder S; Putmans P; Calonne E; Rothé F; Sotiriou C; Fuks F; Deplus R
Mol Biosyst; 2016 Feb; 12(2):404-13. PubMed ID: 26621457
[TBL] [Abstract][Full Text] [Related]
13. The histone-H3K4-specific demethylase KDM5B binds to its substrate and product through distinct PHD fingers.
Klein BJ; Piao L; Xi Y; Rincon-Arano H; Rothbart SB; Peng D; Wen H; Larson C; Zhang X; Zheng X; Cortazar MA; Peña PV; Mangan A; Bentley DL; Strahl BD; Groudine M; Li W; Shi X; Kutateladze TG
Cell Rep; 2014 Jan; 6(2):325-35. PubMed ID: 24412361
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of the histone demethylase, KDM5B, directly induces re-expression of tumor suppressor protein HEXIM1 in cancer cells.
Montano MM; Yeh IJ; Chen Y; Hernandez C; Kiselar JG; de la Fuente M; Lawes AM; Nieman MT; Kiser PD; Jacobberger J; Exner AA; Lawes MC
Breast Cancer Res; 2019 Dec; 21(1):138. PubMed ID: 31805991
[TBL] [Abstract][Full Text] [Related]
15. Depletion of histone demethylase KDM5B inhibits cell proliferation of hepatocellular carcinoma by regulation of cell cycle checkpoint proteins p15 and p27.
Wang D; Han S; Peng R; Jiao C; Wang X; Yang X; Yang R; Li X
J Exp Clin Cancer Res; 2016 Feb; 35():37. PubMed ID: 26911146
[TBL] [Abstract][Full Text] [Related]
16. miR-491-5p functions as a tumor suppressor by targeting JMJD2B in ERα-positive breast cancer.
Hui Z; Yiling C; Wenting Y; XuQun H; ChuanYi Z; Hui L
FEBS Lett; 2015 Mar; 589(7):812-21. PubMed ID: 25725194
[TBL] [Abstract][Full Text] [Related]
17. Connexin 26 is down-regulated by KDM5B in the progression of bladder cancer.
Li X; Su Y; Pan J; Zhou Z; Song B; Xiong E; Chen Z
Int J Mol Sci; 2013 Apr; 14(4):7866-79. PubMed ID: 23579952
[TBL] [Abstract][Full Text] [Related]
18. CUX2/KDM5B/SOX17 Axis Affects the Occurrence and Development of Breast Cancer.
Li L; Zhu G; Tan K; Jiang L; Li Y; Zhu X; Lin Z; Zhang X; Chen J; Ma C
Endocrinology; 2022 Sep; 163(9):. PubMed ID: 35881915
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B virus X protein induces hepatic stem cell-like features in hepatocellular carcinoma by activating KDM5B.
Wang X; Oishi N; Shimakami T; Yamashita T; Honda M; Murakami S; Kaneko S
World J Gastroenterol; 2017 May; 23(18):3252-3261. PubMed ID: 28566884
[TBL] [Abstract][Full Text] [Related]
20. Phosphorylation of the histone demethylase KDM5B and regulation of the phenotype of triple negative breast cancer.
Yeh IJ; Esakov E; Lathia JD; Miyagi M; Reizes O; Montano MM
Sci Rep; 2019 Nov; 9(1):17663. PubMed ID: 31776402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]